Head of eToro US Andrew McCormick says strong 2024 results and better market conditions unlocked the IPO after a four-year ...

Odyssey Therapeutics has withdrawn the initial public offering it filed for in January. The Boston-based biopharmaceutical company on Monday asked the Securities and Exchange Commission to retract the ...

Lauren StClair helped take NerdWallet public in 2021. Now she’s pivoted to become CFO of Slice, which provides services and ...